Strategic question
Our client, one of the major global medical device companies, wanted to identify digital health solutions across five markets: USA, France, Germany, UK and Italy. Their specific focus was to enhance patient care in life changing medical events via personalised support across their therapeutic priorities
How Galen Growth helped
From market signal to decision-ready evidence
Galen Growth combined HealthTech Alpha intelligence with structured ecosystem mapping and market expansion to assess the relevant markets, ventures, and evidence against the client's decision criteria.
Outcomes
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Selecting Cardiac Remote Monitoring Partners for Personalised Patient Care
Which cardiac remote monitoring ventures are mature enough to support personalised patient care across our priority markets?
Selecting Personal Health Ventures for Two Priority Therapeutic Areas
Which personal-health ventures are the optimal fit for our two priority therapeutic areas across the major global ecosystems?
Shortlisting personal health ventures in key therapeutic areas
A global leading medical device company sought to understand the personal health Digital Health landscape for two priority therapeutic areas in key global ecosystems to identify and evaluate relevant ventures